Bifalgorithm post · Canada has the strengths to lead in life sciences · Building on Canada’s advantage

Research Network

Research Network (Canada has the strengths to lead in life sciences · Building on Canada’s advantage) — "BMS Canada invests close to $45-million annually in re…

Ideas in this flowchart

  • BMS Canada’s clinical research investment and scale
  • BMS Canada invests close to $45 million annually in research and development.
  • The company works with institutes across Canada.
  • This collaboration helps build one of Canada’s largest clinical trial networks among major pharmaceutical companies.
  • At the end of 2025, BMS Canada had an extensive active clinical trial program.
  • The company had 100 active trials across multiple therapeutic areas.
  • These trials involved roughly 1,000 patients at nearly 300 sites.
  • BMS ranked among the top five pharmaceutical companies for active trials in Canada.
  • Close to 70 per cent of BMS’s global priority clinical trials are conducted in Canada.
Bifalgorithm
Sign up
Feed/

Research Network

No cover

Channel

Canada has the strengths to lead in life sciences

1 page

U
USR292600b83e2a
Ebook2w

"BMS Canada invests close to $45-million annually in research and development, working with institutes across the country to help build one of Canada’s largest clinical trial networks among major pharmaceutical companies.\n\nAt the end of 2025, the company had 100 active trials across multiple therapeutic areas involving roughly 1,000 patients at nearly 300 sites, ranking among the top five pharmaceutical companies for active trials in Canada. Close to 70 per cent of BMS’s global priority clinical trials are conducted here."

Flowchart preview
👍
0
0 comments0 shares

Sign in to view and post comments.